小细胞肺癌的化学治疗已经取得显著进展,不仅取得75～95%的有效率和20～40%的完全缓解率,而且明显延长了生存期。但是,仅有一小部分病人被认为已经治愈,总的五年生存率大约5%。在长期生存的病例中,局限性小细胞肺癌是弥漫性病例的10倍。今天,由于应用新作用的药物,治疗效果已经改善。为了巩固和维持这种治疗 The chemotherapy of small cell lung cancer has made significant progress, not only achieving an effective rate of 75 to 95% and a complete remission rate of 20 to 40%, but also significantly prolonging the survival period. However, only a small percentage of patients are considered cured and the overall five-year survival rate is about 5%. In the long-term survival cases, localized small cell lung cancer is 10 times more than that of diffuse cases. Today, the therapeutic effect has improved due to the use of new drugs. In order to consolidate and maintain this treatment